serw-MX  [xml]  

 DeCS Categories

D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.519 Molecular Mechanisms of Pharmacological Action .
D27.505.519.389 Enzyme Inhibitors .
D27.505.519.389.092 Adenosine Deaminase Inhibitors .
D27.505.519.389.739 Poly(ADP-ribose) Polymerase Inhibitors .
D27.505.519.389.745 Protease Inhibitors .
D27.505.519.389.745.085 Angiotensin-Converting Enzyme Inhibitors .
D27.505.519.562 Membrane Transport Modulators .
D27.505.519.562.750 Sodium Channel Blockers .
D27.505.519.562.750.100 Acid Sensing Ion Channel Blockers .
D27.505.954 Therapeutic Uses .
D27.505.954.248 Antineoplastic Agents .
D27.505.954.248.692 Poly(ADP-ribose) Polymerase Inhibitors .
F01 Behavior and Behavior Mechanisms .
F01.145 Behavior .
F01.145.544 Inhibition (Psychology) .
F02 Psychological Phenomena .
F02.463 Mental Processes .
F02.463.425 Learning .
F02.463.425.475 Inhibition (Psychology) .
F02.739 Psychological Theory .
F02.739.794 Psychoanalytic Theory .
F02.739.794.405 Inhibition (Psychology) .
 Synonyms & Historicals
Adenosine Deaminase Inhibitors .
ADA Inhibitors .
Deaminase Inhibitors, Adenosine .
Inhibitors, ADA .
Inhibitors, Adenosine Deaminase .
Drugs that inhibit ADENOSINE DEAMINASE activity. .
/antagonists & inhibitors .
/antagonists and inhibitors .
/antagonists .
/inhibitors .
Used with chemicals, drugs, and endogenous substances to indicate substances or agents which counteract their biological effects by any mechanism. .
Angiotensin-Converting Enzyme Inhibitors .
Angiotensin I-Converting Enzyme Inhibitors .
Angiotensin-Converting Enzyme Antagonists .
Antagonists, Angiotensin-Converting Enzyme .
Antagonists, Kininase II .
Inhibitors, ACE .
Inhibitors, Angiotensin-Converting Enzyme .
Inhibitors, Kininase II .
Kininase II Antagonists .
Angiotensin Converting Enzyme Antagonists .
Angiotensin Converting Enzyme Inhibitors .
Angiotensin I Converting Enzyme Inhibitors .
Antagonists, Angiotensin Converting Enzyme .
Enzyme Antagonists, Angiotensin-Converting .
Enzyme Inhibitors, Angiotensin-Converting .
Inhibitors, Angiotensin Converting Enzyme .
Kininase II Inhibitors .
ACE Inhibitors .
A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. .
Acid Sensing Ion Channel Blockers .
ASIC Blockers .
ASIC Channel Antagonists .
ASIC Channel Blockers .
ASIC Inhibitors .
Acid Sensing Ion Channel Inhibitors .
Antagonists, ASIC Channel .
Blockers, ASIC Channel .
Channel Antagonists, ASIC .
Channel Blockers, ASIC .
Proton Gated Sodium Channel Blockers .
Proton-Gated Sodium Channel Blockers .
A subclass of sodium channel blockers that are specific for ACID-SENSING SODIUM CHANNELS. .
Inhibition (Psychology) .
Inhibition .
Inhibitions .
Inhibitions (Psychology) .
The interference with or prevention of a behavioral or verbal response even though the stimulus for that response is present; in psychoanalysis the unconscious restraining of an instinctual process. .
Poly(ADP-ribose) Polymerase Inhibitors .
Inhibitors of Poly(ADP-ribose) Polymerases .
PARP Inhibitors .
Poly(ADP-ribosylation) Inhibitors .
Inhibitors, PARP .
Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES. .